Modern pharmacological research shows that KLTI can down-regulate Bcl-2 and up-regulate p53 gene expression to inhibit tumor growth and metastasis, adjust the expression of NF-κB, IL-2 and other cytokines, promote T cell proliferation, and improve the body's immunity (Chen et al., 2019). Here, TP53 is linked to neoplasm.